Shopping Cart 0
Cart Subtotal
USD 0

Inivata Ltd - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Inivata Ltd (Inivata) is a cancer genomics company. The company offers products such as invisionfirst- lungin and visionseq. Its InVisionFirst offers advanced sequencing technology to detect single nucleotide variants copy number variants, insertions and deletions and structural variants in selected genes from dna isolated from plasma samples from patients with non-small cell lung cancer. Inivata works with industry and academic researchers to develop new clinical applications for liquid biopsy and ctdna analysis. The company offers Liquid biopsies to clinical outcomes. It operates in Canada and the US. Inivata is headquartered in Cambridge, the UK.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Inivata Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Inivata Ltd Company Overview 5

Inivata Ltd Company Snapshot 5

Inivata Ltd Pipeline Products and Ongoing Clinical Trials Overview 5

Inivata Ltd-Pipeline Analysis Overview 7

Inivata Ltd-Key Facts 7

Inivata Ltd-Major Products and Services 8

Inivata Ltd Pipeline Products by Development Stage 9

Inivata Ltd Ongoing Clinical Trials by Trial Status 10

Inivata Ltd Pipeline Products Overview 12

InVision ctDNA Assay-EGFR-Mutant NSCLC 12

InVision ctDNA Assay-EGFR-Mutant NSCLC Product Overview 12

InVision ctDNA Assay-Metastatic Breast Cancer 13

InVision ctDNA Assay-Metastatic Breast Cancer Product Overview 13

InVision ctDNA Assay-NSCLC 14

InVision ctDNA Assay-NSCLC Product Overview 14

InVision ctDNA Assay-NSCLC Clinical Trial 15

InVision ctDNA Assay-Pancreatic Cancer 16

InVision ctDNA Assay-Pancreatic Cancer Product Overview 16

InVision ctDNA Assay-Stage III/IV NSCLC 17

InVision ctDNA Assay-Stage III/IV NSCLC Product Overview 17

InVision First 18

InVision First Product Overview 18

InVision First Clinical Trial 19

Inivata Ltd-Key Competitors 20

Inivata Ltd-Key Employees 21

Inivata Ltd-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Inivata Ltd, Recent Developments 23

Jun 01, 2018: Addario Lung Cancer Medical Institute Collaborates with Washington University on ctDNA Analysis in Early Stage Lung Cancer Study 23

May 08, 2018: Michael Stocum to step down as Inivata CEO 23

Apr 11, 2018: Presentation of New Data on Inivata's Industry-Leading Liquid Biopsy Platform at AACR 2018 Annual Meeting 24

Mar 19, 2018: Inivata Publishes Results of Analytical Validation for InVisionFirst-Lung ctDNA Liquid Biopsy 24

Mar 15, 2018: Inivata Announces Collaboration with MedStar Health to Utilize Liquid Biopsy to Advance Precision Cancer Genomics 25

Oct 26, 2017: Inivata Announces World-Leading SAB 25

Oct 17, 2017: Inivata Highlights New Clinical Data on InVision ctDNA Liquid Biopsy Platform in advanced NSCLC at WCLC 2017 26

Oct 17, 2017: Inivata Highlights New Clinical Data on InVision ctDNA Liquid Biopsy Platform in advanced NSCLC at WCLC 2017 27

Oct 13, 2017: Inivata Collaborates with Genomics England to Assess Samples and Explore Potential of Liquid Biopsy to Improve Cancer Management and Patient Outcomes 28

Sep 27, 2017: Addario Lung Cancer Medical Research Institute and Inivata Announce Major Study of ctDNA Analysis in Early Stage Lung Cancer 28

Appendix 29

Methodology 29

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Inivata Ltd Pipeline Products by Equipment Type 6

Inivata Ltd Pipeline Products by Development Stage 9

Inivata Ltd Ongoing Clinical Trials by Trial Status 10


List Of Table

List of Tables

Inivata Ltd Pipeline Products and Ongoing Clinical Trials Overview 5

Inivata Ltd Pipeline Products by Equipment Type 6

Inivata Ltd Pipeline Products by Indication 6

Inivata Ltd Ongoing Clinical Trials by Trial Status 6

Inivata Ltd, Key Facts 7

Inivata Ltd, Major Products and Services 8

Inivata Ltd Number of Pipeline Products by Development Stage 9

Inivata Ltd Pipeline Products Summary by Development Stage 9

Inivata Ltd Ongoing Clinical Trials by Trial Status 10

Inivata Ltd Ongoing Clinical Trials Summary 11

InVision ctDNA Assay-EGFR-Mutant NSCLC-Product Status 12

InVision ctDNA Assay-EGFR-Mutant NSCLC-Product Description 12

InVision ctDNA Assay-Metastatic Breast Cancer-Product Status 13

InVision ctDNA Assay-Metastatic Breast Cancer-Product Description 13

InVision ctDNA Assay-NSCLC-Product Status 14

InVision ctDNA Assay-NSCLC-Product Description 14

InVision ctDNA Assay-NSCLC-Liquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation: LIBERTI 15

InVision ctDNA Assay-Pancreatic Cancer-Product Status 16

InVision ctDNA Assay-Pancreatic Cancer-Product Description 16

InVision ctDNA Assay-Stage III/IV NSCLC-Product Status 17

InVision ctDNA Assay-Stage III/IV NSCLC-Product Description 17

InVision First-Product Status 18

InVision First-Product Description 18

InVision First-Analytical Validation of a Next Generation Sequencing Liquid Biopsy Assay for High Sensitivity Broad Molecular Profiling 19

InVision First-Evaluation of Liquid Biopsies for Molecular Profiling in Patients with Advanced Non-small Cell Lung Cancer (NSCLC) in the Relapse Treatment Setting 19

InVision First-Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared with Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients with Advanced Non-small Cell Lung Cancer 19

Inivata Ltd, Key Employees 21

Inivata Ltd, Subsidiaries 22

Glossary 31

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Inivata Ltd,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

ANGLE Plc

DiagNodus Ltd

Atlas Genetics Ltd

Summary

Inivata Ltd (Inivata) is a cancer genomics company. The company offers products such as invisionfirst- lungin and visionseq. Its InVisionFirst offers advanced sequencing technology to detect single nucleotide variants copy number variants, insertions and deletions and structural variants in selected genes from dna isolated from plasma samples from patients with non-small cell lung cancer. Inivata works with industry and academic researchers to develop new clinical applications for liquid biopsy and ctdna analysis. The company offers Liquid biopsies to clinical outcomes. It operates in Canada and the US. Inivata is headquartered in Cambridge, the UK.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Inivata Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Inivata Ltd Company Overview 5

Inivata Ltd Company Snapshot 5

Inivata Ltd Pipeline Products and Ongoing Clinical Trials Overview 5

Inivata Ltd-Pipeline Analysis Overview 7

Inivata Ltd-Key Facts 7

Inivata Ltd-Major Products and Services 8

Inivata Ltd Pipeline Products by Development Stage 9

Inivata Ltd Ongoing Clinical Trials by Trial Status 10

Inivata Ltd Pipeline Products Overview 12

InVision ctDNA Assay-EGFR-Mutant NSCLC 12

InVision ctDNA Assay-EGFR-Mutant NSCLC Product Overview 12

InVision ctDNA Assay-Metastatic Breast Cancer 13

InVision ctDNA Assay-Metastatic Breast Cancer Product Overview 13

InVision ctDNA Assay-NSCLC 14

InVision ctDNA Assay-NSCLC Product Overview 14

InVision ctDNA Assay-NSCLC Clinical Trial 15

InVision ctDNA Assay-Pancreatic Cancer 16

InVision ctDNA Assay-Pancreatic Cancer Product Overview 16

InVision ctDNA Assay-Stage III/IV NSCLC 17

InVision ctDNA Assay-Stage III/IV NSCLC Product Overview 17

InVision First 18

InVision First Product Overview 18

InVision First Clinical Trial 19

Inivata Ltd-Key Competitors 20

Inivata Ltd-Key Employees 21

Inivata Ltd-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Inivata Ltd, Recent Developments 23

Jun 01, 2018: Addario Lung Cancer Medical Institute Collaborates with Washington University on ctDNA Analysis in Early Stage Lung Cancer Study 23

May 08, 2018: Michael Stocum to step down as Inivata CEO 23

Apr 11, 2018: Presentation of New Data on Inivata's Industry-Leading Liquid Biopsy Platform at AACR 2018 Annual Meeting 24

Mar 19, 2018: Inivata Publishes Results of Analytical Validation for InVisionFirst-Lung ctDNA Liquid Biopsy 24

Mar 15, 2018: Inivata Announces Collaboration with MedStar Health to Utilize Liquid Biopsy to Advance Precision Cancer Genomics 25

Oct 26, 2017: Inivata Announces World-Leading SAB 25

Oct 17, 2017: Inivata Highlights New Clinical Data on InVision ctDNA Liquid Biopsy Platform in advanced NSCLC at WCLC 2017 26

Oct 17, 2017: Inivata Highlights New Clinical Data on InVision ctDNA Liquid Biopsy Platform in advanced NSCLC at WCLC 2017 27

Oct 13, 2017: Inivata Collaborates with Genomics England to Assess Samples and Explore Potential of Liquid Biopsy to Improve Cancer Management and Patient Outcomes 28

Sep 27, 2017: Addario Lung Cancer Medical Research Institute and Inivata Announce Major Study of ctDNA Analysis in Early Stage Lung Cancer 28

Appendix 29

Methodology 29

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Inivata Ltd Pipeline Products by Equipment Type 6

Inivata Ltd Pipeline Products by Development Stage 9

Inivata Ltd Ongoing Clinical Trials by Trial Status 10


List Of Table

List of Tables

Inivata Ltd Pipeline Products and Ongoing Clinical Trials Overview 5

Inivata Ltd Pipeline Products by Equipment Type 6

Inivata Ltd Pipeline Products by Indication 6

Inivata Ltd Ongoing Clinical Trials by Trial Status 6

Inivata Ltd, Key Facts 7

Inivata Ltd, Major Products and Services 8

Inivata Ltd Number of Pipeline Products by Development Stage 9

Inivata Ltd Pipeline Products Summary by Development Stage 9

Inivata Ltd Ongoing Clinical Trials by Trial Status 10

Inivata Ltd Ongoing Clinical Trials Summary 11

InVision ctDNA Assay-EGFR-Mutant NSCLC-Product Status 12

InVision ctDNA Assay-EGFR-Mutant NSCLC-Product Description 12

InVision ctDNA Assay-Metastatic Breast Cancer-Product Status 13

InVision ctDNA Assay-Metastatic Breast Cancer-Product Description 13

InVision ctDNA Assay-NSCLC-Product Status 14

InVision ctDNA Assay-NSCLC-Product Description 14

InVision ctDNA Assay-NSCLC-Liquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation: LIBERTI 15

InVision ctDNA Assay-Pancreatic Cancer-Product Status 16

InVision ctDNA Assay-Pancreatic Cancer-Product Description 16

InVision ctDNA Assay-Stage III/IV NSCLC-Product Status 17

InVision ctDNA Assay-Stage III/IV NSCLC-Product Description 17

InVision First-Product Status 18

InVision First-Product Description 18

InVision First-Analytical Validation of a Next Generation Sequencing Liquid Biopsy Assay for High Sensitivity Broad Molecular Profiling 19

InVision First-Evaluation of Liquid Biopsies for Molecular Profiling in Patients with Advanced Non-small Cell Lung Cancer (NSCLC) in the Relapse Treatment Setting 19

InVision First-Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared with Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients with Advanced Non-small Cell Lung Cancer 19

Inivata Ltd, Key Employees 21

Inivata Ltd, Subsidiaries 22

Glossary 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Inivata Ltd,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

ANGLE Plc

DiagNodus Ltd

Atlas Genetics Ltd